Last Verified: | July/31/2010 |
First Submitted: | August/7/2010 |
Estimated Enrollment Submitted: | August/8/2010 |
First Posted: | August/9/2010 |
Last Update Submitted: | August/8/2010 |
Last Update Posted: | August/9/2010 |
Actual Study Start Date: | September/30/2010 |
Estimated Primary Completion Date: | November/30/2011 |
Estimated Study Completion Date: | June/30/2012 |
Study Type: | Interventional |
Allocation: | Randomized |
Primary Purpose: | Treatment |
Masking: | Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor) |
Arm | Intervention/treatment |
---|---|
Experimental: Passiflora, Anxiety Disorders 1 tablet Passiflora;Crataegus;Salix; PO;BID | Drug: Passiflora, Anxiety Disorders 01 tablet Passiflora p.o., b.i.d. |
Active Comparator: Valeriane, Anxiety Disorder 1 tablet Valeriana officinalis, PO, BID | Drug: Valeriane, Anxiety Disorder Active Comparator group will receive 01 tablet of Valeriana officinalis, p.o., b.i.d. |
Ages Eligible for Study: | 18 Years to 18 Years |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Criteria: | Inclusion Criteria: - Clinical diagnosis of generalized anxiety disorder - HAM-A scale > 17 and <30 Exclusion Criteria: - HAM-A scale > 30 - Psychotherapy |